# IASO Bio Hosts FUCASO Singapore Launch Event, Marking the Official Commercial Landing of China's Original Fully Human BCMA CAR-T Cell Therapy in Southeast Asia's Healthcare Hub

- Source: PR Newswire M&A
- Published: 2026-11-04T04:59:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/iaso-bio-hosts-fucaso-singapore-launch-event-marking-the-official-commercial-landing-of-chinas-original-fully-human-bcma-car-t-cell-therapy-in-southeast-asias-healthcare-hub-302928816.html
- Canonical: https://groundlevelnews.com/story/iaso-bio-hosts-fucaso-singapore-launch-event-marking-the-official-comm-1ed6cf/

IASO Bio and its Singapore partner Pills and Pokes jointly hosted the FUCASO launch event in Singapore on November 3, marking the official commercial arrival of the world's first fully human BCMA-targeted CAR-T cell therapy in Singapore. FUCASO was approved by Singapore's Health Sciences...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._